About This Resource:

Despite the recognized oncogenicity of certain gene alterations, many still lack established therapeutic options. Our latest research leverages the comprehensive Velsera Knowledgebase (KB), encompassing over 1,250 genes and numerous biomarker-disease-therapy associations, to uncover actionable molecular targets in cancer types with limited treatment options.

Download our poster to dive into the data and learn more about how our findings could shape the future of cancer therapy.